NP_000217.2
[Other Products]
NCBI GenBank Nucleotide #
|
[Other Products]
UniProt Primary Accession #
|
[Other Products]
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
keratin, type I cytoskeletal 9
NCBI Official Synonym Full Names
keratin 9, type I
NCBI Protein Information
keratin, type I cytoskeletal 9
UniProt Protein Name
Keratin, type I cytoskeletal 9
UniProt Synonym Protein Names
Cytokeratin-9; CK-9; Keratin-9; K9
UniProt Synonym Gene Names
UniProt Entry Name
K1C9_HUMAN
NCBI Summary for KRT9
This gene encodes the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this gene cause epidermolytic palmoplantar keratoderma. [provided by RefSeq, Jul 2008]
UniProt Comments for KRT9
K9: a type I cytoskeletal keratin. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. There are two types of cytoskeletal and microfibrillar keratin: type I (acidic; 40-55 kDa) [K9 to K20] and type II (neutral to basic; 56-70 kDa) [K1 to K8]. Both a basic and an acidic keratin are required for filament assembly.
Protein type: Cytoskeletal
Chromosomal Location of Human Ortholog: 17q21.2
Cellular Component: extracellular space; membrane; intermediate filament; nucleus
Molecular Function: structural constituent of cytoskeleton
Biological Process: skin development; epidermis development; intermediate filament organization; spermatogenesis
Disease: Palmoplantar Keratoderma, Epidermolytic
Product References and Citations for anti-KRT9 antibody
Feng,W., Han,W. Eur J Dermatol 18 (4), 387-390 (2008) Zhao,J.J., Zhang,Z.H. Int. J. Dermatol. 47 (6), 634-637 (2008) Torchard,D., Blanchet-Bardon,C. Nat. Genet. 6 (1), 106-110 (1994) Reis,A., Kuster,W. Hum. Genet. 90 (1-2), 113-116 (1992)
Research Articles on KRT9
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Products associated with anti-KRT9 antibody
Diseases associated with anti-KRT9 antibody
|